Quercetin enhances susceptibility to NK cell-mediated lysis of tumor cells through induction of NKG2D ligands and suppression of HSP70

Journal of Immunotherapy

Volumn 33, Issue 4, 2010, Pages 391-401

  Bae, Jae Ho ^a   Kim, Joo Young ^a   Kim, Mi Ju ^a   Chang, Sung Ho ^a   Park, You Soo ^c   Son, Cheol Hun ^c   Park, Soo Jung ^d   Chung, Joo Seop ^a   Lee, Eun Yup ^a   Kim, Sun Hee ^a,b   Kang, Chi Dug ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

^c BINEX Co Ltd   (South Korea)

^d National Masan TB Hospital   (South Korea)

Author keywords

HSPs; NF B; NKG2D ligands; Pi3 k; Quercetin

Indexed keywords

BINDING PROTEIN; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NATURAL KILLER CELL RECEPTOR NKG2D; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; QUERCETIN; UL16 BINDING PROTEIN 1; UL16 BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; DRUG ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

EID: 77954955918     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/CJI.0b013e3181d32f22     Document Type: Article

References (60)

1. Miller JS. The biology of natural killer cells in cancer, infection, and pregnancy. Exp Hematol. 2001;29:1157-1168.
2. Robertson MJ, Ritz J. Biology and clinical relevance of human natural killer cells. Blood. 1990;76:2421-2438.
3. Trinchieri G. Biology of natural killer cells. Adv Immunol. 1989;47:187-376.
4. Lanier LL. NK cell recognition. Annu Rev Immunol. 2005;23:225-274.
5. Lanier LL. Natural killer cell receptor signaling. Curr Opin Immunol. 2003;15:308-314.
6. Farag SS, Fehniger TA, Ruggeri L, et al. Natural killer cell receptors: new biology and insights into the graft-versusleukemia effect. Blood. 2002;100:1935-1947.
7. Diefenbach A, Jensen ER, Jamieson AM, et al. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature. 2001;413:165-171.
8. Zamai L, Ponti C, Mirandola P, et al. NK cells and cancer. J Immunol. 2007;178:4011-4016.
9. Ljunggren HG, Malmberg KJ. Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol. 2007;7:329-339.
10. Groh V, Bahram S, Bauer S, et al. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A. 1996;93:12445-12450.
11. Borchers MT, Harris NL, Wesselkamper SC, et al. NKG2D ligands are expressed on stressed human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2006;291: L222-L231.
12. Groh V, Rhinehart R, Randolph-Habecker J, et al. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol. 2001;2:255-260.
13. Gasser S, Orsulic S, Brown EJ, et al. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature. 2005;436:1186-1190.
14. Kim JY, Bae JH, Lee SH, et al. Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide. J Immunother. 2008;31:475-486.
15. Kim JY, Son YO, Park SW, et al. Increase of NKG2D ligands and sensitivity to NK cell-mediated cytotoxicity of tumor cells by heat shock and ionizing radiation. Exp Mol Med. 2006;38:474-484.
16. Armeanu S, Bitzer M, Lauer UM, et al. Natural killer cellmediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Cancer Res. 2005;65:6321-6329.
17. Reddy RM, Yeow WS, Chua A, et al. Rapid and profound potentiation of Apo2L/TRAIL-mediated cytotoxicity and apoptosis in thoracic cancer cells by the histone deacetylase inhibitor Trichostatin A: the essential role of the mitochondriamediated caspase activation cascade. Apoptosis. 2007;12:55-71.
18. Armeanu S, Krusch M, Baltz KM, et al. Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma. Clin Cancer Res. 2008;14:3520-3528.
19. Hallett WH, Ames E, Motarjemi M, et al. Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition. J Immunol. 2008;180:163-170.
20. Grivicich I, Regner A, Zanoni C, et al. Hsp70 response to 5-fluorouracil treatment in human colon cancer cell lines. Int J Colorectal Dis. 2007;22:1201-1208.
21. Yang WL, Yang-Biggs G, Wu Y, et al. Development of cross-resistance between heat and cisplatin or hydroxyurea treatments in FaDu squamous carcinoma cells. J Surg Res. 2003;111:143-151.
22. Pan T, Li X, Xie W, et al. Valproic acid-mediated Hsp70 induction and anti-apoptotic neuroprotection in SH-SY5Y cells. FEBS Lett. 2005;579:6716-6720.
23. Chen T, Sun H, Lu J, et al. Histone acetylation is involved in hsp70 gene transcription regulation in Drosophila melanogaster. Arch Biochem Biophys. 2002;408:171-176.
24. Calvaruso G, Giuliano M, Portanova P, et al. Hsp72 controls bortezomib-induced HepG2 cell death via interaction with pro-apoptotic factors. Oncol Rep. 2007;18:447-450.
25. Calini V, Urani C, Camatini M. Overexpression of HSP70 is induced by ionizing radiation in C3H 10T1/2 cells and protects from DNA damage. Toxicol In vitro. 2003;17:561-566.
26. Hettinga JV, Lemstra W, Meijer C, et al. Heat-shock protein expression in cisplatin-sensitive and-resistant human tumor cells. Int J Cancer. 1996;67:800-807.
27. Samali A, Cotter TG. Heat shock proteins increase resistance to apoptosis. Exp Cell Res. 1996;223:163-170.
28. Garrido C, Brunet M, Didelot C, et al. Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle. 2006;5:2592-2601.
29. Pocaly M, Lagarde V, Etienne G, et al. Overexpression of the heat-shock protein 70 is associated to imatinib resistance in chronic myeloid leukemia. Leukemia. 2007;21:93-101.
30. Roigas J, Wallen ES, Loening SA, et al. Effects of combined treatment of chemotherapeutics and hyperthermia on survival and the regulation of heat shock proteins in Dunning R3327 prostate carcinoma cells. Prostate. 1998;34:195-202.
31. Jakubowicz-Gil J, Rzymowska JA. Quercetin, apoptosis, heat shock. Biochem Pharmacol. 2002;64:1591-1595.
32. Formica JV, Regelson W. Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol. 1995;33:1061-1080.
33. Matter WF, Brown RF, Vlahos CJ. The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. Biochem Biophys Res Commun. 1992;186:624-631.
34. Singhal RL, Yeh YA, Praja N, et al. Quercetin down-regulates signal transduction in human breast carcinoma cells. Biochem Biophys Res Commun. 1995;208:425-431.
35. Garcia-Roman R, Salazar-Gonzalez D, Rosas S, et al. The differential NF-kB modulation by S-adenosyl-L-methionine, N-acetylcysteine and quercetin on the promotion stage of chemical hepatocarcinogenesis. Free Radic Res. 2008;42:331-343.
36. Park SW, Bae JH, Kim SD, et al. Comparison of level of NKG2D ligands between normal and tumor tissue using multiplex RT-PCR. Cancer Invest. 2007;25:299-307.
37. Nylandsted J, Brand K, Jaattela M. Heat shock protein 70 is required for the survival of cancer cells. Ann N Y Acad Sci. 2000;926:122-125.
38. Jaattela M, Wissing D, Bauer PA, et al. Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity. Embo J. 1992;11:3507-3512.
39. Rusak G, Gutzeit HO, Ludwig-Muller J. Effects of structurally related flavonoids on hsp gene expression in human promyeloid leukaemia cells. Food Technol. Biotechnol. 2002;40:267-273.
40. Ren W, Qiao Z, Wang H, et al. Flavonoids: promising anticancer agents. Med Res Rev. 2003;23:519-534.
41. Nagai N, Nakai A, Nagata K. Quercetin suppresses heat shock response by down regulation of HSF1. Biochem Biophys Res Commun. 1995;208:1099-1105.
42. Tang D, Kang R, Xiao W, et al. Quercetin prevents lipopolysaccharide- induced HMGB1 release and proinflammatory function. Am J Respir Cell Mol Biol. 2009;41:651-660.
43. Vales-Gomez M, Chisholm SE, Cassady-Cain RL, et al. Selective induction of expression of a ligand for the NKG2D receptor by proteasome inhibitors. Cancer Res. 2008;68:1546-1554.
44. Eagle RA, Traherne JA, Ashiru O, et al. Regulation of NKG2D ligand gene expression. Hum Immunol. 2006;67:159-169.
45. Lopez-Soto A, Quinones-Lombrana A, Lopez-Arbesu R, et al. Transcriptional regulation of ULBP1, a human ligand of the NKG2D receptor. J Biol Chem. 2006;281:30419-30430.
46. Yamamoto K, Fujiyama Y, Andoh A, et al. Oxidative stress increases MICA and MICB gene expression in the human colon carcinoma cell line (CaCo-2). Biochim Biophys Acta. 2001;1526:10-12.
47. Jinushi M, Takehara T, Tatsumi T, et al. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int J Cancer. 2003;104:354-361.
48. Tang KF, He CX, Zeng GL, et al. Induction of MHC class I-related chain B (MICB) by 5-aza-20-deoxycytidine. Biochem Biophys Res Commun. 2008;370:578-583.
49. Groh V, Steinle A, Bauer S, et al. Recognition of stressinduced MHC molecules by intestinal epithelial gammadelta T cells. Science. 1998;279:1737-1740.
50. Boissel N, Rea D, Tieng V, et al. BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia. J Immunol. 2006;176:5108-5116.
51. Molinero LL, Fuertes MB, Girart MV, et al. NF-kappa B regulates expression of the MHC class I-related chain A gene in activated T lymphocytes. J Immunol. 2004;173:5583-5590.
52. Dosenko VE, Nagibin VS, Tumanovskaia LV, et al. Effect of quercetin on the activity of purified 20S and 26S proteasome and proteasomal activity in isolated cardiomyocytes. Biomed Chem. 2007;1:40-44.
53. Fuertes MB, Girart MV, Molinero LL, et al. Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity. J Immunol. 2008;180:4606-4614.
54. Catley MC, Cambridge LM, Nasuhara Y, et al. Inhibitors of protein kinase C (PKC) prevent activated transcription: role of events downstream of NF-kappaB DNA binding. J Biol Chem. 2004;279:18457-18466.
55. Holden NS, Squires PE, Kaur M, et al. Phorbol esterstimulated NF-kappaB-dependent transcription: roles for isoforms of novel protein kinase C. Cell Signal. 2008;20:1338-1348.
56. Kang CD, Han CS, Kim KW, et al. Activation of NF-kappaB mediates the PMA-induced differentiation of K562 cells. Cancer Lett. 1998;132:99-106.
57. Ryves WJ, Evans AT, Olivier AR, et al. Activation of the PKC-isotypes alpha, beta 1, gamma, delta and epsilon by phorbol esters of different biological activities. FEBS Lett. 1991;288:5-9.
58. Castagna M, Takai Y, Kaibuchi K, et al. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem. 1982;257:7847-7851.
59. Schultz H, Engel K, Gaestel M. PMA-induced activation of the p42/44ERK-and p38RK-MAP kinase cascades in HL-60 cells is PKC dependent but not essential for differentiation to the macrophage-like phenotype. J Cell Physiol. 1997;173:310-318.
60. Yu CS, Lai KC, Yang JS, et al. Quercetin inhibited murine leukemia WEHI-3 cells in vivo and promoted immune response. Phytother Res. 2009:163-168.